CTRL Enables Gene-Specific RNA Regulation Using CRISPR-Cas7-11.

Abstract

Advancements in synthetic biology have enabled the development of precision gene expression technologies for comprehensive investigations of biological and biochemical networks. Here, we describe the development of a refined and innovative tool, CRISPR-Cas Transgenic Repressible eLement (CTRL), which utilizes the direct repeat processing activity of the recently discovered CRISPR-Cas7-11 effector to site-specifically target synthetic mRNA molecules. We demonstrate that CTRL exhibits high efficiency, tunable regulation of expression, and gene-specific repression of mRNA and protein expression. We engineered multiple permutations of the Cas7-11 effector that differ in their ability to reduce gene expression, suggesting flexibility for the application of choice. CTRL is a novel variation on gene repression technology that exhibits broad applicability across multiple model systems.

Evidence profile

Study type

laboratory

Text reviewed by the copilot

Full text is available

Publication status

published

Corrections or retractions

none

Conflict statement

Not supplied in the PubMed record

Topics and methods

Ask about this paper